Walts Ann E, Bose Shikha
Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Clin Med Pathol. 2008;1:35-42. doi: 10.4137/cpath.s522. Epub 2008 Mar 19.
Cervical metaplastic squamous epithelium exhibiting atypia insufficient for a diagnosis of cervical intraepithelial neoplasia (CIN) is usually reported as "atypical squamous metaplasia" (ASM). Stratification impacts treatment since the differential is often between reactive and high grade CIN (CIN II, III). Diagnosis with H&E is associated with low intra/interobserver concurrence. P16/Ki-67 immunostains are helpful to assess cervical biopsies for HPV-associated lesions but staining in metaplastic squamous epithelium has received little attention. This study aims to establish staining characteristics of metaplastic squamous epithelium and determine if p16/Ki-67 is useful in ASM stratification. 80 cervical biopsies containing morphologically normal and dysplastic squamous metaplasia were retrieved to determine the staining characteristics of metaplastic epithelium utilizing p16/Ki-67 immunostains. These included 21 benign squamous metaplasia (BSM) from benign cervices, 15 BSM present adjacent to HPV/CIN lesions, and 44 CIN involving squamous metaplasia. Serial sections with controls were stained for p16 and Ki-67 and in-situ hybridization (ISH) for low-risk (LR) and high-risk (HR) HPV was performed. P16 was recorded as negative, spotty, or band-like. Ki-67 was recorded as positive when present in >50% of lesional nuclei. Results were correlated with H&E diagnosis. 95% of the BSMs, whether from normal cervices or adjacent to HPV/CIN were p16/Ki-67 negative. 81% HG CINs involving squamous metaplasia were p16 band/Ki-67 positive. Low grade CIN (CIN I) involving metaplastic epithelium showed a broad distribution of p16/Ki-67 staining patterns. Based on these criteria, 20 ASM were evaluated. 10% of the ASM cases were p16 band/Ki-67 positive indicating HG CIN. 60% of the ASMs were p16/Ki-67 negative indicating reactive change (all with the exception of one case being HPV negative). The remaining 30% of the ASM cases showed variable positivity for p16 and Ki-67 and could not be stratified into the two categories. Thus p16/Ki-67 staining is helpful in stratification of ASM as reactive or CIN.
表现出的异型性不足以诊断为宫颈上皮内瘤变(CIN)的宫颈化生鳞状上皮通常报告为“非典型鳞状化生”(ASM)。分层影响治疗,因为鉴别诊断通常在反应性和高级别CIN(CIN II、III)之间。苏木精和伊红(H&E)染色诊断的观察者间/观察者内一致性较低。P16/Ki-67免疫染色有助于评估宫颈活检中的人乳头瘤病毒(HPV)相关病变,但化生鳞状上皮中的染色情况鲜受关注。本研究旨在确定化生鳞状上皮的染色特征,并确定p16/Ki-67在ASM分层中是否有用。检索了80例包含形态学正常和发育异常的鳞状化生的宫颈活检组织,利用p16/Ki-67免疫染色确定化生上皮的染色特征。这些组织包括21例来自良性宫颈的良性鳞状化生(BSM)、15例存在于HPV/CIN病变附近的BSM以及44例累及鳞状化生的CIN。带有对照的连续切片进行p16和Ki-67染色,并进行低风险(LR)和高风险(HR)HPV的原位杂交(ISH)。P16记录为阴性、斑点状或带状。当Ki-67在超过50%的病变细胞核中出现时记录为阳性。结果与H&E诊断相关。95%的BSM,无论来自正常宫颈还是邻近HPV/CIN,p16/Ki-67均为阴性。81%累及鳞状化生的高级别CIN为p16带状/Ki-67阳性。累及化生上皮的低级别CIN(CIN I)显示p16/Ki-67染色模式分布广泛。基于这些标准,对20例ASM进行了评估。10%的ASM病例为p16带状/Ki-67阳性,提示高级别CIN。60%的ASM为p16/Ki-67阴性,提示反应性改变(除1例HPV阴性外均如此)。其余30%的ASM病例p16和Ki-67呈可变阳性,无法分为两类。因此,p16/Ki-67染色有助于将ASM分层为反应性或CIN。